Applying Non-Homogeneous Dose Optimization to Improve Conventionally Fractionated Radiation Plan Quality in Patients with Non-Small Cell Lung Cancer

Keyphrases

• Non-small Cell Lung Cancer (NSCLC) 100%
• Dose Optimization 100%
• Fractionated Radiation 100%
• Plan Quality 100%
• Conventionally Fractionated 100%
• Fractionated Radiation Therapy 31%
• Stereotactic Body Radiation Therapy 15%
• Lung 10%
• Tumor 10%
• Mean Dose 10%
• Optimization Techniques 10%
• Planning Target Volume 10%
• Target Coverage 10%
• Tumor Control Probability 10%
• Dose Fall-off 10%
• Normal Tissue Constraints 10%
• Optimization Plan 10%
• At-risk 5%
• Prescription Drugs 5%
• Dose Reduction 5%
• Single Institution 5%
• Wilcoxon Signed-rank Test 5%
• Esophagus 5%
• Relative Reduction 5%
• Prescription Isodose Line 5%
• Dose Delivery 5%
• Median Value 5%
• Isodose Line 5%
• Dose Constraints 5%
• Normal Tissue Toxicity 5%
• Optimization Principle 5%
• Volume Coverage 5%
• Dose Heterogeneity 5%
• Radiotherapy Optimization 5%

Medicine and Dentistry

• Non Small Cell Lung Cancer 100%
• Radiation Therapy 100%
• Neoplasm 66%
• Stereotactic Body Radiation Therapy 50%
• Lung 33%
• Drug Dose Reduction 16%
• Esophagus 16%
• Wilcoxon Signed Ranks Test 16%
• Drug Dose Increase 16%